129 related articles for article (PubMed ID: 19947179)
1. Seroprevalence of hepatitis C infection and associated risk factors among addicted prisoners in Sari-Iran.
Zakizad M; Salmeh F; Yaghoobi T; Yaghoubian M; Nesami MB; Esmaeeli Z; Vaezzadeh N; Shahmohammadi S; Modanloo S; Sadeghian AA; Abdolmanafi SJ; Mohammadpour RA; Siamian H; Khosravi A
Pak J Biol Sci; 2009 Jul; 12(14):1012-8. PubMed ID: 19947179
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of Hepatitis C Virus among Prisoners in Lakan Prison, North of Iran, Is There Still a Concern?
Mohtasham-Amiri Z; Rezvani SM; Ashoori F; Behboodi M; Toosi H; Jafari-Shakib R
Arch Iran Med; 2021 Oct; 24(10):765-770. PubMed ID: 34816699
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001-2006).
Alavi SM; Alavi L
J Infect Public Health; 2009; 2(1):47-51. PubMed ID: 20701860
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study.
SeyedAlinaghi S; Farhoudi B; Shahmohamadi E; Rasoolinejad M; Hasannezhad M; Rashidi MR; Dadras O; Moradi A; Parmoon Z; Ebrahimi H; Asadollahi-Amin A
Int J Prison Health; 2023 Feb; ():. PubMed ID: 36757302
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison.
Okafor IM; Ugwu SO; Okoroiwu HU
BMC Gastroenterol; 2020 Oct; 20(1):360. PubMed ID: 33126856
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection.
Guimarães T; Granato CF; Varella D; Ferraz ML; Castelo A; Kallás EG
Braz J Infect Dis; 2001 Jun; 5(3):111-8. PubMed ID: 11506773
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London.
Aisyah DN; Shallcross L; Hayward A; Aldridge RW; Hemming S; Yates S; Ferenando G; Possas L; Garber E; Watson JM; Geretti AM; McHugh TD; Lipman M; Story A
J Viral Hepat; 2018 Nov; 25(11):1260-1269. PubMed ID: 29851232
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran.
Mohammad Alizadeh AH; Alavian SM; Jafari K; Yazdi N
World J Gastroenterol; 2005 Jul; 11(26):4085-9. PubMed ID: 15996035
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases.
Mohamed HI; Saad ZM; Abd-Elreheem EM; Abd-ElGhany WM; Mohamed MS; Abd Elnaeem EA; Seedhom AE
J Infect Public Health; 2013 Jun; 6(3):186-95. PubMed ID: 23668463
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway.
Holsen DS; Harthug S; Myrmel H
Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):673-6. PubMed ID: 7694850
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Prevalence of Hepatitis B, Hepatitis C, and HIV in Inmates with Drug-Related Convictions in Birjand, Iran in 2008.
Azarkar Z; Sharifzadeh G
Hepat Mon; 2010; 10(1):26-30. PubMed ID: 22308122
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015.
Moradi G; Gouya MM; Azimizan Zavareh F; Mohamadi Bolbanabad A; Darvishi S; Aghasadeghi MR; Nabavi M; Alasvand R; Tashakorian M; Nouri B; Rahmani K; Molaei L
Trop Med Int Health; 2018 Jun; 23(6):641-649. PubMed ID: 29698576
[TBL] [Abstract][Full Text] [Related]
16. [Drug-addicted prisoners: seroprevalence of human immunodeficiency virus and hepatitis B and C virus soon after the marketing of buprenorphine].
Claudon-Charpentier A; Hoibian M; Glasser P; Lalanne H; Pasquali JL
Rev Med Interne; 2000 Jun; 21(6):505-9. PubMed ID: 10909149
[TBL] [Abstract][Full Text] [Related]
17. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors associated with HIV infection, hepatitis and syphilis in a state prison of São Paulo.
El Maerrawi I; Carvalho HB
Int J STD AIDS; 2015 Feb; 26(2):120-7. PubMed ID: 24733152
[TBL] [Abstract][Full Text] [Related]
19. PRE-DONATION SCREENING OF VOLUNTEER PRISONER BLOOD DONORS FOR HEPATITIS B AND C IN PRISONS OF PUNJAB, PAKISTAN.
Pervaiz A; Sipra FS; Rana TH; Qadeer I
J Ayub Med Coll Abbottabad; 2015; 27(4):794-7. PubMed ID: 27004325
[TBL] [Abstract][Full Text] [Related]
20. [Infection with hepatitis C virus in a prison environment. A prospective study in Loos-lez-Lille, France].
Hedouin V; Gosset D
Gastroenterol Clin Biol; 1998 Jan; 22(1):55-8. PubMed ID: 9762167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
